Remove Compound Screening Remove Development Remove Genetics Remove Trials
article thumbnail

What to expect from drug discovery and development in 2023

Drug Discovery World

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.

article thumbnail

AI use in repurposing drugs for Covid-19

Drug Discovery World

Clinical trials revealed eight out of nine predictions were correct. We witnessed the unprecedented pace of vaccine development, fuelled by cutting-edge mRNA technology. Today, there have been efficacy readouts from large randomised controlled clinical trials for nine of our predictions – eight of which we predicted correctly.

Drugs 59
article thumbnail

Re-assessing the risks of drug-induced arrhythmias during drug discovery

Drug Discovery World

Although such electrophysiological systems may be more predictive of potential cardiac safety and efficacy than non-functional binding assays, many apparently attractive new drugs are still being discontinued later in development. Unexpected late-stage failures in drug development are, of course, the costliest.

Drugs 52